CYP3A drives several DDC metabolic pathways in mouse liver but is not essential for N-methyl protoporphyrin IX formation
- Untargeted metabolomics in mouse liver S9 fractions identified several CYP-dependent metabolites of the porphyria-inducing chemical DDC.
- CYP3A contributed to multiple biotransformation routes, including a previously undescribed pathway involving deamination followed by cyclization.
- In mice lacking Cyp3a, DDC-driven N-methyl protoporphyrin IX formation, protoporphyrin accumulation and liver injury were not appreciably altered, so CYP3A appears dispensable for generating this porphyrin.
💡 Points Based on the abstract
Good news for anyone worried about CYP3A-mediated DDC bioactivation: the Cyp3a-null result says NMPP formation runs through other P450s, so CYP3A inhibitors or inducers won't be the lever here. Next step is isoform mapping with other Cyp families, or a Cyp reductase knockout, since redundancy likely masks the culprit. Mouse-to-human porphyrin handling also needs checking before reading across.